Nio, EVgo, and Navitas will all profit from the electric vehicle market's recovery.Many electric vehicle (EV) stocks soared in 2020 and 2021, but a lot of them fizzled out over the following years as rising interest rates chilled the hot market. Price wars, supply chain disruptions, inflation, higher tariffs, and intensifying trade wars exacerbated that pressure.However, investors who can look past those near-term headwinds might find some promising plays in what has become an out-of-favor sector. I believe ...

Core Points - Laurent-Perrier appointed three new Board Observers during the General Meeting on July 10, 2025, to enhance the understanding of the Group's strategic challenges [3][4] - The new appointees are Maximilien Meneux, Luana Meneux, and Léa Pereyre, representing the next generation of the family involved in the company [3][4] - Laurent-Perrier is a publicly listed family-owned champagne house focused on the high-end market, with a diverse product portfolio [8] Group Structure - The appointments were made under the supervision of Patrick Thomas, Chairman of the Supervisory Board [3] - Léa Pereyre, 33, has a background in Industrial Design and has worked on various interdisciplinary projects, including digital education initiatives [5] - Luana Meneux, 25, holds a Master's in Product Design and has experience in industrial design, along with a WSET Diploma [6] - Maximilien Meneux, 28, specializes in Neuroscience and has taken on a directorial role in a subsidiary of Laurent-Perrier [7] Company Overview - Laurent-Perrier is one of the few champagne houses listed on the stock market, exclusively dedicated to champagne and known for its high-quality products [8] - The company operates under several renowned brands, including Laurent-Perrier, Salon, Delamotte, and Champagne de Castellane [8] - It is included in the Euronext indices PEA-PME 150 and Euronext FAMILY BUSINESS, indicating its significance in the market [8]

Core Viewpoint - Viewbix Inc. has entered into agreements for the sale of approximately $4.5 million shares of common stock and pre-funded warrants, aiming to explore new business opportunities and investments in various sectors [1][2][4]. Group 1: Transaction Details - The company will issue a total of 925,923 units, with common units priced at $4.86 each and pre-funded units priced similarly, minus a pre-funded warrant exercise price of $0.0001 [3]. - Each unit consists of one share of common stock and one common warrant, with an exercise price of $4.74 per share, valid for 5.5 years from issuance [3]. - The closing of the private placement is expected around July 14, 2025, pending customary closing conditions, with gross proceeds anticipated to be approximately $4.5 million before fees and expenses [4]. Group 2: Use of Proceeds - The net proceeds from the offering, along with existing cash, will be utilized for general corporate purposes and working capital [4]. Group 3: Company Overview - Viewbix operates in digital advertising through subsidiaries Gix Media Ltd. and Cortex Media Group Ltd., focusing on search and digital content [7]. - The search segment develops software solutions for automating, optimizing, and monetizing internet campaigns, while the digital content segment creates and edits content for various target audiences to generate revenue from major advertising platforms [7].

Core Insights - Frequency Electronics, Inc. reported significant revenue growth for the fiscal year 2025, with revenues of approximately $20.0 million for Q4 and $69.8 million for the full year, compared to $15.6 million and $55.3 million in the previous fiscal year [1] - The company achieved an operating income of $3.3 million for Q4 and $11.7 million for the full year, up from $2.5 million and $5.0 million in the prior year [1] - Net income from operations for Q4 was $3.3 million ($0.34 per diluted share) and $23.8 million ($2.48 per diluted share) for the full year, compared to $2.6 million ($0.28 per diluted share) and $5.6 million ($0.59 per diluted share) in FY2024 [1] Financial Performance - Q4 revenues from satellite payloads were approximately $12.1 million, representing 60% of consolidated revenues, compared to $6.9 million (44%) in the same period of FY2024 [6] - Revenues from non-space U.S. Government/DOD customers were approximately $7.0 million (35%) for Q4, down from $7.9 million (51%) in FY2024 [6] - Total revenues from other commercial and industrial sales accounted for approximately $0.9 million (4%) for Q4, slightly up from $0.8 million (5%) in the previous year [7] Strategic Outlook - The company is well-positioned to capitalize on the growing quantum sensor market, leveraging its expertise in atomic clocks and actively hiring skilled professionals in this field [5] - FEI is investing in targeted internal R&D to develop products for space and defense applications, aiming for faster execution and reduced customization needs [4] - The recent U.S. budget legislation indicates strong government commitment to space and defense, which FEI anticipates will positively impact its business in the medium to long term [3] Operational Metrics - Net cash used in operating activities was approximately $1.4 million for FY2025, a decline from $8.7 million in FY2024 [12] - The backlog at April 30, 2025, was approximately $70 million, down from $78 million at the same time in the previous year [12]

Core Insights - REGENXBIO Inc. announced preclinical results showing that a microdystrophin gene therapy construct with the C-terminal (CT) domain provides improved functional benefits for patients with Duchenne Muscular Dystrophy compared to a construct without the CT domain [1][4][5] - RGX-202 is the only investigational microdystrophin gene therapy candidate that includes the CT domain, making it closest to naturally occurring dystrophin [2][8] Group 1: Research Findings - The preclinical study published in Molecular Therapy Methods and Clinical Development demonstrated that the microdystrophin with the CT domain was maintained at higher levels in transduced muscles and effectively recruited the dystrophin-associated protein complex to the muscle membrane [4][5] - The incorporation of the CT domain enhances the microdystrophin design, allowing for higher accumulation levels in muscle and potentially improving functional benefits [5][7] Group 2: Clinical Trial Insights - Interim results from the Phase I/II AFFINITY DUCHENNE trial indicated that RGX-202 showed consistent evidence of positively changing the disease trajectory in patients with Duchenne and had a favorable safety profile [5][6] - REGENXBIO is currently enrolling participants in the pivotal portion of the Phase I/II/III AFFINITY DUCHENNE trial and plans to submit a Biologics License Application (BLA) via the accelerated approval pathway in mid-2026 [6][9] Group 3: Company Overview - REGENXBIO is a biotechnology company focused on gene therapy, with a late-stage pipeline that includes RGX-202 for Duchenne, among other treatments for rare diseases [11] - The company has pioneered AAV gene therapy since its founding in 2009 and has treated thousands of patients with its AAV platform [11]

Byrna Technologies (BYRN) Q2 2025 Earnings Call July 10, 2025 09:00 AM ET Speaker0Good morning. Welcome to Brno's Fiscal Second Quarter twenty twenty five Earnings Conference Call. My name is Daryl, and I will be your operator for today's call. Joining us for today's presentation are the company's CEO, Brian Gantz and CFO, Lori Kearns. Following their remarks, we will open the call to questions.Earlier today, Berner released results for its fiscal second quarter ended 05/31/2025. A copy of the press release ...

Byrna Technologies (BYRN) Q2 2025 Earnings Call July 10, 2025 09:00 AM ET Company ParticipantsBryan Ganz - CEO, President & DirectorLauri Kearnes - CFOJon Hickman - MD - Equity ResearchConference Call ParticipantsMatthew Koranda - MD & Senior Research AnalystJeff Van Sinderen - Senior AnalystOperatorGood morning. Welcome to Brno's Fiscal Second Quarter twenty twenty five Earnings Conference Call. My name is Daryl, and I will be your operator for today's call. Joining us for today's presentation are the comp ...

Customers Don't Have to Change Their Energy Use to SaveOAKLAND, Calif., July 9, 2025 /PRNewswire/ -- One simple change could make a big difference in your energy bill. Pacific Gas and Electric Company (PG&E) is encouraging customers to check that they are on the lowest-cost rate plan for their home or business.Customers can find their lowest rate simply by logging into their PG&E online account and using the Rate Comparison tool.PG&E forecasts no additional electric rate increases for the rest of 2025. The ...

Momentum investing revolves around the idea of following a stock's recent trend in either direction. In the 'long' context, investors will be essentially be "buying high, but hoping to sell even higher." With this methodology, taking advantage of trends in a stock's price is key; once a stock establishes a course, it is more than likely to continue moving that way. The goal is that once a stock heads down a fixed path, it will lead to timely and profitable trades.While many investors like to look for moment ...

Zoom AI Companion now connects with 16 third-party apps, including ServiceNow, Jira, Asana, Box, and others, to complete tasks and orchestrate agents without leaving ZoomCustom AI Companion add-on is now available to online customers, delivering extended capabilities, including AI meeting summaries across top meeting platforms and customized meeting summariesZoom expands core AI Companion capabilities, including real-time call questions, voice recorder for in-person meetings, and meeting agenda creation, in ...